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Apoptosis in mesangial cells induced by ionizing radiation and cyto.
toxic drugs. Mesangial proliferation contributes to the pathogenesis of
many forms of glomerulonephritis. To evaluate the role of apoptosis on
the pharmacologic effects of cytotoxic drugs and ionizing radiation, we
studied their effects on cultured rat mesangial cells (MC), whose apoptotic
response to these drugs is unknown. Mesangial cells were cultured with or
without stimuli to induce apoptosis and were harvested at 24 and 48 hours.
MC morphology was examined by light microscopy, in situ end labeling
technique using terminal deoxy-transferase (TUNEL) and by electro-
phoresis of extracted total cellular DNA. MCs exposed to cytotoxic drugs
or irradiation demonstrated statistically significant increases in apoptotic
cells identified by light microscopy. DNA fragmentation of apoptotic cells
was also visualized as characteristic staining by the TUNEL method and
statistically significant increases in apoptotic cell number in cells exposed
to cytotoxic drugs and irradiation were noted compared to control
cultures. In general, the number of TIJNEL positive cells was greater than
that of morphologically apoptotic cells. DNA extracted from these cells
also showed the characteristic ladder pattern of internucleosomal chro-
matin cleavage of 180 bp fragments on agarose gel electrophoresis. To
further analyze whether MC apoptosis induced by these drugs alters the
cell cycle, 3H-thymidine incorporation rates were measured in both the
cell culture monolayer and in those cells shed into the supernatant when
cultured with or without cyclophosphamide (N = 5). 3H-thymidine
incorporation corrected for total cellular DNA showed a similar pattern in
both control and cyclophosphamide treated groups, suggesting that cyclo-
phosphamide did not alter the mesangial cell cycle. Considering that the
dosage of the cytotoxic drugs utilized in these experiments is nearly the
therapeutic plasma level in humans, these results suggest that cytotoxic
drugs used to treat glomerular disease can induce apoptotic mesangial cell
death and may operate in part via this mechanism.
Glomerular mesangial cell proliferation plays an important role
in the pathogenesis of many types of progresssive glomcrular
disease [1, 2]. Nevertheless, mechanisms regulating the turnover
of mesangial cells under normal and pathologic conditions are at
present poorly understood. As one of the mechanisms controlling
cell turnover, programmed cell death or apoptosis is now consid-
ered an important physiological process. Apoptosis was first
described in 1972 [3], and it is now accepted that this process is
involved in a number of biological processes such as embryogen-
esis, tissue remodeling, immunologic development and tumor
regression [4, 5]. Although physiological cell death has been
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known for decades, it has not been thought to play an important
role in renal disease. In 1987, Harrison first reported evidence of
apoptosis in diseased human glomeruli [6] and proposed that
apoptosis is a protective mechanism helping to reduce severe
glomerular injusy. Thereafter, the significance of the apoptotic
process has been increasingly recognized in various human and
experimental glomerular disorders, including nephrotoxic nephri-
tis [7, 8], mesangial proliferative glomerulonephritis [9], lupus
nephritis [10, 11] and polycystic kidney disease [12].
It is widely assumed that cell death induced by a range of
anticancer drugs maybe mediated by apoptosis [13, 14]. However,
there is no information on whether cytotoxic drugs used currently
or historically to treat proliferative glomerular disease can induce
this process in mesangial cells. Therefore, the question arose as to
whether programmed cell death is induced in mesangial cells
following treatment with these drugs. To investigate the role of
apoptosis in the pharmacologic effects of cytotoxic drugs and
ionizing radiation, we studied the effects of these drugs on
cultured rat mesangial cells by using the techniques of histologic
examination, DNA agarose gel electrophoresis, in situ end label-
ing (TUNEL), and 3H-thymidine incorporation studies.
Methods
Materials
Dexamethasone was purchased from Sigma Chemical Company
(St. Louis, MO, USA), cyclophosphamide from Adria Laborato-
ries (Columbus, OH, USA), meiphalan from Burroughs Well-
come Company (London, UK), and cyclosporine A was obtained
From Sandoz (Basel, Switzerland).
Methods
Glomerular isolation and mesangial cell culture
Renal glomeruli were isolated from male Spraguc-Dawley rats
(Charles River Laboratories, Wilmington, MA, USA) weighing
250 to 300 g. Kidneys were removed, glomeruli isolated by
differential sieving, and isolated glomeruli were incubated in
collagenase and trypsin-EDTA (Gibco Laboratories, Bethesda,
MD, USA) as described previously [15]. Identification of mesan-
gial cells were performed by their characteristic stellate appear-
ance in culture and confirmed by immunofluorescent microscopy
for the presence of actin, myosin, and Thy-i antigen [16] and the
absence of factor VIII and cytokeratin (Synbiotics, San Diego,
CA, USA). Mesangial cells were maintained in RPM! 1640
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(Mediatech Inc., Herndon, VA, USA) supplemented with L-
glutamine, HEPES 7 mivi (Gibco), penicillin 100 U/mi, strepto-
mycin 100 U/mI, amphotericin 1.25 mg/mI, insulin 15 jsg/ml
(Gibco Laboratories), 15% fetal calf serum (Hyclone Laborato-
ries, Logan, UT, USA) and incubated at 37°C in humidified 5%
CO2 in air. All cells were used at passage numbers 4 to 6.
Induction of apoptosis
Preparation of cytotoxic drugs. To investigate the effects of
cytotoxic drugs under pharmacologic conditions, drugs were pre-
pared to a concentration near therapeutic plasma levels in hu-
mans (10 M) and also at higher concentrations. Dexamethasone
was dissolved in DMEM medium, and added to the medium at
final concentrations of l06 M and 10 M. Cyclophosphamide was
dissolved in PBS and used at a concentration of 5 X 10 M and
iO M. Meiphalan was dissoved in diluent containing 0.2 g
sodium citrate, 60% propylene glycol, and 5.2% ethanol just
before use, and added to culture medium at final concentrations
of 2 X i0 M and iO M. Cyclosporine A was dissolved in PBS
containing 1% DMSO, and used at a concentration of 100 ng/ml
and 1000 ng/ml.
Irradiation of mesangial cells. All of the culture plates were
positioned in the center of the X-ray beam delivered by a 4
mev/Varian therapy X-ray unit (Palo Alto, CA, USA), with a
target distance of 8 cm. A total of 500 Rads was applied and doses
were measured using a dosimeter.
Histologic examination. Mesangial cells were plated at a density
of 3 X i0 cells/well onto 4-chamber glass slides in RPM! 1640
containing 15% FCS, grown to subconfluence and synchronized in
Go by incubation in RPM! with 0.5% FCS for 24 hours. Then
MCs were cultured in RPMI 1640 containing 15% FCS with or
without stimuli to induce apoptosis, and harvested at 24 and 48
hours. All slides were fixed using 10% buffered formalin fume at
room temperature for three days, and stained with hematoxylin-
eosin. For quantitation of the percentage of apoptotic cells in each
condition, 200 cells from randomly selected fields were examined
on each slide (N = 6). Mesangial cells were counted as apoptotic
if their light microscopic appearance was that of fragmentation
with pyknotic nuclei and condensed chromatin. Some MCs were
cultured in RPM! medium without serum for three days to induce
apoptosis, and were used as a positive control. As a negative
control, some MCs were cultured in RPM! medium containing
15% FCS for 24 and 48 hours without cytotoxie drugs.
In situ end labeling (TUNEL). TUNEL staining was performed
to further substantiate the apoptosis identified by light micro-
scopic findings in mesangial cells exposed to cytotoxie drugs and
ionizing irradiation. This study was done in non-synchronized
mesangial cells to investigate the effects of cytotoxie drugs and
ionizing irradiation under more physiologic conditions. For this
experiment, the ApoTag in situ apoptosis detection kit (Oneor
Inc., Gaithersburg, MD, USA) was used. A total of 3 X I 0
cells/well were plated onto 4-chamber glass slides, cultured with
RPM! 1640 containing 15% FCS and incubated with or without
eytotoxic drugs for 24 hours. Then slides were fixed at room
temperature for 20 minutes with 4% formaldehyde in PBS.
Terminal deoxytransferase (TDT) and digoxigenin-dUTP in TDT
buffer were then added to cover the slide, and slides incubated in
a humidified chamber at 37°C for two hours. The reaction was
terminated by adding the stop/wash buffer for 30 minutes at 37°C,
and incubated in the anti-digoxigenin-peroxidase solution for 50
minutes at room temperature. The slides were then rinsed with
PBS for 15 minutes at room temperature, and stained with 3,3'-
diaminobenzidine tetrahydrochloride (Sigma) substrate solution
containing 0.02% hydrogen peroxidase for 30 minutes at room
temperature. Then slides were eounterstained with methyl green
for 30 seconds, washed in 100% butanol, and mounted with
histomount.
DNA fragmentation analysis. MCs were plated at a density of I 0
cells per each 75 ml flask, and incubated under the experimental
conditions described above. After incubation, cells were pelleted
at 4°C, and resuspended in 0.5 ml of lysis buffer (5 mi Tris-HC1,
pH 8.0, 20 mrvi EDTA, 0.5% Triton X-100). Then 0.4 mg/mI of
proteinase K was added and the cells incubated at 55°C for one
hour. DNA extraction was performed by using a phenol/chioro-
form/isoamyl alcohol (25:24:1) method, with precipitation in cold
absolute ethanol containing 0.1 xi final concentration of NaCl, and
centrifugation for two minutes at 4°C and 14,000 g. The pellet was
then resuspended in TE buffer (10 mrvi Tris-HCI, pH 7.4, 1 mxi
EDTA) containing 0.3 mg/mI DNAse free RNAse A, and further
incubated overnight at 37°C. Then 10 g of DNA were loaded
into the wells of a 2% agarose gel, electrophoresis performed
overnight and the gel stained with ethidium bromide. A 100 hp
DNA ladder (Gibeo) was used to determine the size of the
fragments.
Cell cycle analysis. To determine the effects of cyclophospha-
mide on the mesangial cell cycle, 1.2 X 106 mesangial cells per
well were plated in pentaplicate in 6 well plates, allowed to grow
to subconfluence, and synchronized with RPMI medium with
0.5% FCS for 24 hours. Thereafter medium was changed to RPMI
containing 15% FCS with or without cyclophosphamide at a final
concentration of 5 X 10 M, and harvested at 4,8, 11, 14 and 24
hours. Methyl-3H-thymidine (87 Ci/mmol; Amersham, Arlington
Heights, IL, USA) was added at 0.25 Ci/ml to each well two
hours before harvesting of cells. At the time of harvest, floating
cells in the culture medium were collected separately from the
monolayer. The cells were washed twice with cold PBS, precipi-
tated twice with cold 5% trichloroacetic acid, washed with abso-
lute ethanol two times, and air dried. The pellet was dissolved in
I N NaOH and counted by a liquid scintillation counter. All counts
were corrected by the total DNA amount in each well, the latter
measured as previously described [171.
Results
Morphologic evidence of apoptosis
Before treatment, synchronized mesangial cells grew in mono-
layers and showed a characteristic stellate appearance with
smooth peripheral cell borders. Twenty-four hours after treat-
ment with cytotoxic drugs or irradiation, however, significant
numbers of cells demonstrated the typical morphology of apopto-
sis including pyknotic nuclei, chromatin condensation, nuclear
fragmentation and apoptotic bodies (Figs. I and 2).
Effects of cylotoxic drugs and irradiation on MC apoplosis
For determination of the percentage of apoptotic cells studied
under each condition, synchronized mesangial cells were fixed
with 10% formalin and 200 cells from randomly selected micro-
scopic fields were examined on each slide (N = 6) by light
microscopy to determine the number with condensed chromatin,
pyknotic nuclei and fragmentation.
aa
Cha et al: Cytotoxic dmgs and mesangial cell apoptosis 1567
Fig. 1. Mesangial cells from the different experimental groups after 24 hours of exposure. MCs were fixed with 10% buffered formalin fume at room
temperature for three days, and stained with hematoxylin-eosin. Note the differing rates of apoptosis (arrows pointing to representative apoptotic cells).
A. Control. B. Dexamethasone 10—6 M. C. yclophosphamide 5 >< i0 M. D. Meiphlan 2 >< l0' M. E. Cyclosporine A 1000 ng/ml. F. Irradiation 500
Rads. (All X125)
Fig. 2. High magnification of representative synchronized mesangial cells after 24 hours exposure, fixed with formalin fumes and stained with hematoxylin and
eosin. A. Control showing normal mesangial cells. B. Cyclophosphamide 5 X 10 M. C. irradiation 500 Rads showing representative apoptotic mesangial
cells with nuclear fragments and condensed cytoplasm (All X500),
Dexamethasone induced significant apoptotic cell death at both 0.001) after 48 hours of incubation, respectively, compared to the
concentrations of 10 'M and iO M. The percentage of apoptotic control apoptotic rate of 2.6 0.6% and 4.0 1.0% after 24 and
cells rose to 12.3 0.9% and 8.8 0.7% (P < 0.001) at each 48 hours of incubation (Table 1). yclophosphamide also induced
concentration after 24 hours, 14.2 1.5 and 13.4 1.1% (P < a significant increase in apoptotie change after 24 hours of
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Table 1. Light microscopic findings of effects of cytotoxic drugs and
ionizing radiation on mesangial cell apoptosis
24 Hours incubation 48 Hours incubation
% of apoptosis % of apoptosis
2.6 0.6 4.0 1.0
12.3 0.9c 14.2 i.s
8.8 o.D 13.4 1.1',
8.8 1.2 11.6 1.06
14.6 1.2c 15.9 196
23.0 2.5' 23.8 1.7'
15.2 1.4c 30.5 6.7
11.3 14h 14.3 0.8c




Cyclophosphamide5 > 10 M
Cyclophosphamide i0 M




Mesangial cells synchronized in GO by pre-incubation in 0.5% FCS ><
24 hours were cultured in the presence of cytotoxic drugs for 24 and 48
hours. After treatments, cells were fixed and 200 randomly selected cells
were counted. The values shown arc the mean su from 6 slides of each
condition.
Statistically significant differences from control: a P < 0.05, 6 P < 0.001,
P < 0.0001
incubation; 8.8 1.2% and 14.6 1.2% (P < 0.05). After 48
hours, the apoptotic rate further rose to 11.6 1.0% and 15.9
1.9% (P < 0.001) compared to control. The apoptotic change in
mesangial cells was most significant with meiphalan or irradiation
exposure. In mesangial cells treated with melphalan for 24 hours
at a concentration of 2 X 106 M and io— M, apoptosis was
present in 23.0 2.5% and 15.2 1.4%, respectively (P <
0.0001), and these changes further increased to 23.8 1.7% and
30.5 6.7% after 48 hours of incubation. Irradiated mesangial
cells also showed a significant increase in apoptotic rate to 18.0
1.8% (P < 0.0001) after 24 hours incubation and 24.7 2.3%
(P < 0.0001) after 48 hours of incubation. Cyclosporine A,
administered at a supraphysiological concentration, also induced
significant apoptosis of 11.3 1.4% and 14.3 0.8% after 24 and
48 hours of incubation, respectively (P < 0.001).
In situ end labeling
These experiments were performed in non-synchronized mes-
angial cells to confirm the light microscopic evidence of apoptosis
using a second method of apoptosis identification (such as
TUNEL staining) and to examine the apoptotic process under
more physiologic conditions. With TUNEL staining, apoptosis
was demonstrated by the characteristic positive nuclear staining
(Fig. 3). Apoptotic rates under these conditions are summarized
in Table 2. Alter 24 hours of treatment with dexamethasone at
M and iO M respectively, the percentage of apoptotic cells
rose to 17.0 2.2% (P < 0.005) and 23.2 3.6% (P < 0.0001)
compared to the control apoptotic rate of 1.5 1.2%. Cyclophos-
phamide induced a significant increase in apoptotic change after
24 hours incubation: 12.7 3.2% (P < 0.01) and 25.1 2.8%
(P < 0.0001) at concentrations of 5 X l0 M and iO— M. The
apoptotic change in cyclosporine A treated mesangial cells was
also significant: 15.9 2.9% (P < 0.005) and 23.0 2.2% (P <
0.0001) at concentrations of 100 ng/ml and 1000 ng/ml. Irradiated
mesangial cells showed the most significant increase in apoptotic
rate to 45.2 6.1% (P < 0.0001) after 24 hours. In these
experiments, the number of positive nuclei were more than that
identified as apoptotic by purely morphological criteria (Tables I
and 2). For example, for mesangial cells exposed to cyclophos-
phamide for 24 hours at a concentration of io— M, there were
25.1 2.8% TUNEL positive cells compared to 14.6 1.2%
identified by light microscopy (P < 0.05), a finding consistent with
the increased sensitivity of the TUNEL method [181.
Agarose gel electrophoresis
DNA extracted from mesangial cells incubated under standard
conditions to serve as controls showed almost entirely high
molecular weight DNA, whereas DNA from serum starved cells
(positive controls) or cells treated with dexamethasone, cytotoxic
drugs, or irradiation revealed the characteristic ladder pattern of
internucleosomal chromatin cleavage of 180 bp fragments (Fig. 4).
Effects of cyclophosphamide on the mesangial cell cycle
3H-thymidine incorporation was measured with or without
cyclophosphamide in the culture medium to investigate its effect
on the mesangial cell cycle. Considering that most of the apoptotie
cells are likely to be present in the supernatant, 3H-thymidine
incorporation was measured separately in the floating cells as well
as in the cells of the monolayers. The results are shown in Figure
5.
In the monolayer, 3H-thymidine incorporation corrected for
total cellular DNA showed a peak value near 11 hours after
incubation in both control and cyclophosphamide treated cells. In
the floating cells, peak 3H-thymidine incorporation was delayed
slightly compared to that observed in the monolayers. Although
the degree of peak 3H-thymidine incorporation in cyclophospha-
mide treated cells was significantly lower than that of control cells
(P < 0.005), there was no difference in peak 3H-thymidine
incorporation time between control and cyclophosphamide
treated cells.
Discussion
The identification of potential mechanisms triggering mesangial
cell apoptosis has clinical significance in that mesangial cell
hyperplasia is a common feature in many forms of glomerulone-
phritis. In recent years, several authors have reported mesangial
cell apoptosis as a major mechanism in the resolution of glomer-
ular hypercellularity in various human and experimental prolifer-
ative forms of glomerulonephritis [9, 19—21]. The main interest of
such studies, however, has focused on the naturally occurring
apoptotic process during resolution of mesangial proliferation.
The present results demonstrate the ability of cytotoxic drugs and
ionizing irradiation to induce the apoptotic death of mesangial
cells. This effect was confirmed by quantitative morphologic
assessments, by electrophoretic demonstrations of cleaved inter-
nucleosomal sites in extracted DNA, and by in situ end labeling
(TUNEL). Morphologically, by routine light microscopic staining
by hematoxylin-eosin staining, mesangial cells undergoing apopto-
tic cell death were easily recognizable, and occurred individually
or in very small groups surrounded by normal mesangial cells.
They had a condensed basophilic chromatin, a small amount of
eosinophilic cytoplasm, and in some areas apoptotic bodies could
be found. These findings were consistent with typical morphologic
changes previously observed in programmed cell death [22—24].
Eleetrophoresis of DNA from cells damaged with these treat-
ments clearly demonstrated the characteristic multimerie pattern
of internucleosomal cleavage of genomic DNA. It is widely
assumed that this type of DNA digestion is the result of selective
. S.
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Fig. 3. Non-synchronized mesangial cells treated with cytotoxic drugs and ionizing irradiation for 24 hours. TUNEL staining was performed using terminal
deoxynucleotidyl transferase (TdT), an enzyme which catalyzes incorporation of digoxigenin-deoxyuridine at sites of DNA breaks. The reaction was
amplified by peroxidase enzyme. Apoptotic cells identified by in situ end labeling (TUNEL) appear as dark nuclei (brown when viewed in color)
(arrows). A. Control. B. Dexamethasone 106 M. C. Cyclophosphamide 5 >< iO M. D. Cyclosporine A 100 nglml. E. Irradiation 500 Rads.
Table 2. Effects of cytotoxic drugs and ionizing irradiation on













Dexamethasone 10 ' M





Non-synchronized mesangial cells were cultured in RPMI 1640 contain-
ing 15% FCS. in Situ end labeling was done after treatment of mesangial
cells with or without cytotoxic drugs or irradiation for 24 hours. MCs were
fixed and 200 randomly selected cells were counted. The values shown are
the mean SE from 4 slides of each condition.
Statistically significant differences from control: a p < 0.01, h P < 0.005,
"P < 0.0001
activation of an endogenous endonuclease capable of cleaving
chromatin at internucleosomal sites [25—27]. It has been also
considered that activation of this enzyme appears to be responsi-
ble not only for widespread chromatin cleavage but also for the
major nuclear morphologic changes [28, 29]. The final indicator of
apoptosis used in this study was the in situ end labeling (TUNEL)
method, which is reported to be highly sensitive in detecting
fragmented DNA [18, 30, 311. Our apoptotic mesangial cells
clearly revealed a distinct nuclear staining pattern, and more
positive cells were noted than were evident by standard light
microscopy. Taken together, these observations demonstrate that
cytotoxic drugs and ionizing radiation can induce cell death in
mesangial cells by the process of apoptosis. It is, however, unclear
how these treatments induce mesangial cell apoptosis. Glucocor-
ticoids have been known to induce apoptotic cell death in
thymocytes and other lymphoid cells associated with progressive
changes in several aspects of cell function, such as decrease in
uptake of glucose, nucleoside, and diminished production of
adenosine triphosphate (ATP) [32—34]. It has also been reported
that the anti-inflamatory effect of corticosteroids are related to
eosinophil apoptosis [35]. Unfortunately, however, the mecha-
nism of glucocorticoid induced apoptosis is not established yet
Fig. 4. DNA gel electrophoresis. Total DNA was prepared from cells after
treatment with cytotoxic drugs or irradiation, and electrophoresed on a 2%
agarose gel in the presence of 0.5 gImi ethidium bromide. Lane 1, dcxameth-
asonc (10—6 M) treated cells. Lane 2, cyclophosphamide (5 X 10 M)
treated cells. Lane 3, melphalan (2 x 106 M) treated cells. Lane 4,
cyclosporine A (1000 ng/ml) treated cells. Lane 5, irradiated cells (500
Rads). Lane 6, positive control (mesangial cells deprived of serum for
three days). Lane 7, negative control (mesangial cells grown in standard
medium).
even in leukocytes. It is considered that several factors may be
operative such as induction of new proteins having DNAse activity
[36], specific gene activation [371, activation of the protein kinase
C pathway [38], and synthesis of heat labile cytosolic factors
facilitating influx of extracellular calcium [39]. The mesangial cell
apoptosis shown in this experiment demonstrates biochemical
activation of endoriuclease, but further studies are required to
elucidate the mechanisms. Various cytotoxic drugs including
cyclophosphamide, meiphalan and ionizing radiation may share
common features in damaging cellular DNA [28].
In viva, cyclophosphamide is known to become cytotoxic after
oxidation by hepatic microsomal enzymes to form 4-hydroxy-
cyclophosphamide [40]. Although mixed function oxidase systems
have not been previously identified in glomerular mesangial cells,
the apoptosis in mesangial cells induced by cyclophosphamide in
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Cyclophosphamide Control Monolayer cells
B treated cells cells
Iii iI
________________
Cyclophosphamide Control Supernatant cells
treated cells cells
Fig. 5. Effcts of cyclophosphamide on the mesangial cell cycle 3H-thymi-
dine inco/poration was measured after incubation of mesangial cells with (A)
or without (B) cyclophosphamide (5 >< 10 si) after synchronization with
RPMI 1640 with 0.5% FCS for 24 hours. MCs were precipitated with 5%
trichloroacetic acid and dissolved in 1 N NaOH and counted by liquid
scintillation counter. 3H-thymidine incorporation was corrected for total
DNA. The absolute amount of peak 3H-thymidine incorporation in
cyclophosphamide treated cells collected from the supernatant was signif-
icantly lower than that of control cells collected from the supernatant.
Symbols are: (E) 0 hour incubation; (U 4 hour incubation; () 8 hour
incubation; () 11 hour incubation; () 14 hour incubation; (L ) 24 hour
incubation. *p < 0.01, significantly different peak values. All data were
derived from 5 different sets of MCs in each group.
this experiment indicate that there may be a mixed function
oxidase system in glomerular mesangial cells. In this experiment,
cyclosporinc A at a therapeutic and a high concentration also
induced significant mesangial cell apoptosis. yclosporine A
interferes with T cell receptor (TCR) mediated lymphocyte
apoptosis, and most published studies demonstrate that cyclospo-
rine A is an inhibitor of apoptotic cell death at a concentrations
between 25 and 200 ng/ml [41]. However, Saiagh et al showed that
cyclosporine A (10 mg/kg of body wt) induces thymic atrophy in
vivo associated with thymocyte apoptosis [421. Thus the latter
study suggested that cyclosporine A could induce programmed
cell death, hut via unknown mechanisms.
It has been reported that enhanced p53 expression is induced by
DNA damage, and a series of additional studies suggest a critical
role of p53 expression in programmed cell death caused by DNA
damaging agents [431. p53 has been implicated in controlling a
checkpoint during the Gi phase of the cell cycle that may monitor
the state of the DNA before entry into S phase [441. An increase
in p53 levels may induce a series of genes that may be required for
growth arrest and DNA repair functions [451. In addition, ele-
vated levels of p53 may inhibit the transcription of other genes
that promote cell proliferation and cell division such as c:fos and
c-jun [46]. Accordingly, loss of control of the cell cycle by this gene
in response to DNA damage could lead to apoptotic cell death.
It is therefore possible that mesangial cell apoptosis induced by
DNA damaging agents might be activated by p53 and reflected in
cell cycle alterations. For identification of this possibility, a cell
cycle study was performed using 3H-thymidine incorporated into
DNA as a marker of DNA synthesis. There was no difference in
either the time to peak thymidine incorporation or in absolute
incorporation in the control and cyclophosphamide treated cells.
However, it is of interest that there was an accumulation of cells
that incorporated 3H-thymidine late in the cycle (such as at 14 and
24 hr) in the supernatant cells as compared to the monolayer cells.
Because the population of cells shed into the supernatant are
likely to be enriched for apoptotic cells, this result suggests that
cell cycle progression to or through S phase may be altered in
mesangial cells undergoing apoptosis. This behavior is consistent
with previous findings demonstrating that the cyclophosphamide
derivative mafosfamide induces S phase accumulation and G2 cell
cycle arrest in HL6O leukemic cells [47].
Taken together, the observations described here demonstrate
that cytotoxic agents used to treat proliferative glomerulonephri-
tis can induce mesangial cell apoptosis. However these observa-
tions raise several unresolved questions. Firstly, how do cytotoxic
drugs induce mesangial cell apoptosis? Recent studies have
emphasized the importance of apoptosis-related genes during this
process [48, 49]. Mesangial cells reportedly express proteins
related to apoptosis, such as fas, bcl-2, and clusterin [50,51]. Thus,
it is probable that apoptosis-related genes are operative in mes-
angial cell apoptosis. Secondly, can mesangial cell apoptosis be
induced by cytotoxie drugs in vivo? In vivo studies will be required
to resolve this problem. Lastly, will pharmacologic manipulation
of programmed cell death eventually make it possible to treat
proliferative glomerulopathies? In summary, this experiment
demonstrates that cytotoxic drugs and ionizing irradiation induce
apoptotie mesangial cell death. Considering that the dosages of
the cytotoxic drugs used in this study approached therapeutic
plasma levels in humans, our observations further raise the
possibility that the beneficial effects of cytotoxie drugs used to
treat glomerular disease may be operative in part via this mech-
anism.
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